Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-016128)

Filing Details

Accession Number:: 0001181431-12-016128
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-03-09 19:02:07
Reporting Period:: 2011-08-22

Filing Date:: 2012-03-09
Accepted Time:: 2012-03-09 19:02:07
Original Submission Date:: 2011-09-30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425205	Genesis Biopharma Inc	GNBP.OB	Arrangement Of Transportation Of Freight & Cargo (4731)	753254381

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1412295	Martin Schroeder	Emmes Group Consulting Llc 92 Natoma Street., #200 San Francisco CA 94105		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-22	1,000,000	$0.00	1,000,000	No	4	P	Indirect	See footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote.

Footnotes

Mr. Schroeder is Executive Vice President and Managing Director of Emmes Group Consulting LLC.